An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1969 • 16,855 citations

The Global Deterioration Scale for assessment of primary degenerative dementia

1982 • 4,700 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>

1998 • 753 citations

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

2001 • 723 citations

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup>

1999 • 581 citations

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

2001 • 505 citations

To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease

2001 • 486 citations

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

2000 • 265 citations

A new rating scale for dementia syndromes

1982 • 262 citations

Alzheimer's Disease Care: Costs And Potential Savings

1998 • 252 citations

Scales to measure competence in everyday activities.

1988 • 238 citations

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer’s disease

1999 • 236 citations

Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study

1996 • 209 citations

Economic Considerations in Alzheimer's Disease

1998 • 197 citations

Measurement of quality-of-life changes in patients with Alzheimer's disease.

1989 • 186 citations

Cost of Alzheimer's Disease and Related Dementia in Managed‐Medicare

1999 • 152 citations

Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada

1999 • 126 citations

Economic impact of Alzheimer's disease in the United Kingdom

1999 • 99 citations

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: A Markov model

1999 • 96 citations

An economic evaluation of donepezil in the treatment of Alzheimer's disease

1998 • 95 citations

The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials

2000 • 75 citations

The Relationship Between Donepezil and Behavioral Disturbances in Patients With Alzheimer's Disease

2000 • 72 citations

Savings in the cost of caring for patients with Alzheimer's disease in Canada: An analysis of treatment with rivastigmine

2000 • 65 citations

Cost of illness due to dementia in Sweden

1997 • 56 citations

Impact of Donepezil on Caregiving Burden for Patients With Alzheimer's Disease

2000 • 52 citations

Treatment of Alzheimer disease with tacrine: a cost-analysis model.

1997 • 42 citations

Assessing the Societal Impact of Acetylcholinesterase Inhibitor Therapies

1999 • 36 citations

Donepezil use in managed medicare: Effect on health care costs and utilization

1999 • 35 citations

Minimizing bias in industry-sponsored outcomes research.

1994 • 25 citations

Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.

1998 • 23 citations

The Relationship Between Donepezil and Behavioral Disturbances in Patients With Alzheimer's Disease

2000 • 18 citations

The costs and social burdens of Alzheimer disease: what can and should be done?

1997 • 13 citations

Functional MRI: current use and future prospects in human and animal research

2000 • 2 citations